{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:38:57Z","timestamp":1792492737345,"version":"4.5.0"},"reference-count":65,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"unspecified","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,9,30]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/bmjopen-2026-118484","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:45:20Z","timestamp":1792489520000},"page":"e118484","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Characterising patients in England with Down syndrome and Alzheimer\u2019s disease: a descriptive observational study using data from Clinical Practice Research Datalink linked to Hospital Episode Statistics"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0717-7963","authenticated-orcid":false,"given":"Ana Sofia","family":"Afonso","sequence":"first","affiliation":[{"name":"Eli Lilly Nederland B.V, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Bracknell, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Carragher","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Casey","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Basingstoke, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj","family":"Patel","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Basingstoke, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"2026102002451214000_16.10.e118484.1","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"key":"2026102002451214000_16.10.e118484.2","unstructured":"National Health Service . Overview: Alzheimer\u2019s disease. 2024. Available: https:\/\/www.nhs.uk\/conditions\/alzheimers-disease\/ [Accessed 27 Feb 2025]."},{"key":"2026102002451214000_16.10.e118484.3","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer\u2019s disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimer's & Dementia"},{"key":"2026102002451214000_16.10.e118484.4","unstructured":"National Down Syndrome Society . About down syndrome. 2024. Available: https:\/\/ndss.org\/about"},{"key":"2026102002451214000_16.10.e118484.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00245-3"},{"key":"2026102002451214000_16.10.e118484.6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-075800","article-title":"Estimating the prevalence of diagnosed Alzheimer disease in England across deprivation groups using electronic health records: a clinical practice research datalink study","volume":"13","author":"Leahy","year":"2023","journal-title":"BMJ Open"},{"key":"2026102002451214000_16.10.e118484.7","unstructured":"National health service England digital . NCARDRS congenital anomaly official statistics report, 2021. 2024. Available: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/ncardrs-congenital-anomaly-statistics-annual-data\/ncardrs-congenital-anomaly-statistics-report-2021\/prevalence-of-t21-t18-t13"},{"key":"2026102002451214000_16.10.e118484.8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026102002451214000_16.10.e118484.9","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14604","article-title":"Risk of Alzheimer\u2019s disease in Down syndrome: Insights gained by multi\u2010omics","volume":"21","author":"Qu","year":"2025","journal-title":"Alzheimer's & Dementia"},{"key":"2026102002451214000_16.10.e118484.10","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1002\/alz.13779","article-title":"Age of Alzheimer\u2019s disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium","volume":"20","author":"Larsen","year":"2024","journal-title":"Alzheimers Dement"},{"key":"2026102002451214000_16.10.e118484.11","first-page":"353","article-title":"Alzheimer\u2019s Disease in Down Syndrome","volume":"1","author":"Head","year":"2012","journal-title":"Eur J Neurodegener Dis"},{"key":"2026102002451214000_16.10.e118484.12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35018","article-title":"Alzheimer Dementia Among Individuals With Down Syndrome","volume":"7","author":"Rubenstein","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026102002451214000_16.10.e118484.13","unstructured":"National Down Syndrome Society . Aging and down syndrome: A health and well-being guidebook. 2013."},{"key":"2026102002451214000_16.10.e118484.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7750(10)39004-5"},{"key":"2026102002451214000_16.10.e118484.15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104692","article-title":"Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels","volume":"94","author":"Murray","year":"2023","journal-title":"EBioMedicine"},{"key":"2026102002451214000_16.10.e118484.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2017.04.006"},{"key":"2026102002451214000_16.10.e118484.17","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70357","article-title":"PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populations","volume":"21","author":"McVea","year":"2025","journal-title":"Alzheimers Dement"},{"key":"2026102002451214000_16.10.e118484.18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/jamaneurol.2018.3616","article-title":"Association of dementia with mortality among adults with Down syndrome older than 35 years","volume":"76","author":"Hithersay","year":"2019","journal-title":"JAMA Neurol"},{"key":"2026102002451214000_16.10.e118484.19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12910","article-title":"Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome","volume":"5","author":"Iulita","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026102002451214000_16.10.e118484.20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/jar.12446","article-title":"Early death and causes of death of people with Down syndrome: A systematic review","volume":"31","author":"O\u2019Leary","year":"2018","journal-title":"J Appl Res Intellect Disabil"},{"key":"2026102002451214000_16.10.e118484.21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3233\/JAD-231488","article-title":"Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer\u2019s disease and related dementias: Findings from United States Medicare claims data","volume":"102","author":"Schroeder","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"2026102002451214000_16.10.e118484.22","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.749305","article-title":"Comorbidity Trajectories Associated With Alzheimer\u2019s Disease: A Matched Case-Control Study in a United States Claims Database","volume":"15","author":"Butler","year":"2021","journal-title":"Front Neurosci"},{"key":"2026102002451214000_16.10.e118484.23","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3233\/JAD-215312","article-title":"Demographics and Medication Use of Patients with Late-Onset Alzheimer\u2019s Disease in Hong Kong","volume":"87","author":"Wong","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"2026102002451214000_16.10.e118484.24","article-title":"Medical Comorbidities and Association With Mortality Risk in Alzheimer\u2019s Disease: Population-Based Study of 132,405 Geriatric Inpatients","volume":"12","author":"Yen","year":"2020","journal-title":"Cureus"},{"key":"2026102002451214000_16.10.e118484.25","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1377\/hlthaff.2022.00520","article-title":"Excluding People With Disabilities From Clinical Research: Eligibility Criteria Lack Clarity And Justification","volume":"41","author":"DeCormier Plosky","year":"2022","journal-title":"Health Aff (Millwood)"},{"key":"2026102002451214000_16.10.e118484.26","unstructured":"Clinical Leader . Why are we still excluding persons with disabilities (PWDs) in clinical trials? 2024. Available: https:\/\/www.clinicalleader.com\/doc\/why-are-we-still-excluding-persons-with-disabilities-pwds-in-clinical-trials-0001 [Accessed 24 Oct 2025]."},{"key":"2026102002451214000_16.10.e118484.27","doi-asserted-by":"crossref","DOI":"10.1186\/s11689-022-09435-z","article-title":"Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group","volume":"14","author":"Baumer","year":"2022","journal-title":"J Neurodev Disord"},{"key":"2026102002451214000_16.10.e118484.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-013473","article-title":"\u201cBeing disabled\u201d as an exclusion criterion for clinical trials: a scoping review","volume":"8","author":"Camanni","year":"2023","journal-title":"BMJ Glob Health"},{"key":"2026102002451214000_16.10.e118484.29","unstructured":"National Health Service Digital . Hospital episode statistics (HES). 2025. Available: https:\/\/digital.nhs.uk\/services\/hospital-episode-statistics [Accessed 1 Apr 2025]."},{"key":"2026102002451214000_16.10.e118484.30","unstructured":"Clinical Practice Research Datalink . Introduction to CPRD. 2024. Available: https:\/\/www.cprd.com\/introduction-cprd [Accessed 1 Apr 2025]."},{"key":"2026102002451214000_16.10.e118484.31","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz034"},{"key":"2026102002451214000_16.10.e118484.32","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv098"},{"key":"2026102002451214000_16.10.e118484.33","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12045"},{"key":"2026102002451214000_16.10.e118484.34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-121819","article-title":"Epidemiology, co-morbidities, and medication use of patients with Alzheimer\u2019s disease or vascular dementia in the UK","volume":"35","author":"Imfeld","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"2026102002451214000_16.10.e118484.35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/JAD-201534","article-title":"Infectious Disease Burden and the Risk of Alzheimer\u2019s Disease: A Population-Based Study","volume":"81","author":"Douros","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"2026102002451214000_16.10.e118484.36","unstructured":"Clinical Practice Research Datalink . Safeguarding patient data. 2024. Available: https:\/\/www.cprd.com\/safeguarding-patient-data [Accessed 3 Mar 2025]."},{"key":"2026102002451214000_16.10.e118484.37","unstructured":"Clinical Practice Research Datalink . Characterization of the Alzheimer\u2019s disease population within England, including sub-group analysis of Alzheimer\u2019s disease patients with down syndrome. 2024. Available: https:\/\/www.cprd.com\/approved-studies\/characterization-alzheimers-disease-population-within-england-including-sub-group [Accessed 3 Mar 2025]."},{"key":"2026102002451214000_16.10.e118484.38","unstructured":"Clinical Practice Research Datalink . CPRD Aurum December 2023. 2023."},{"key":"2026102002451214000_16.10.e118484.39","unstructured":"Clinical Practice Research Datalink . CPRD aurum ethnicity record may 2022. 2023. Available: https:\/\/www.cprd.com\/cprd-aurum-ethnicity-record-may-2022 [Accessed 20 Mar 2025]."},{"key":"2026102002451214000_16.10.e118484.40","unstructured":"Clinical Practice Research Datalink . Hospital episode statistics (HES) admitted patient care and CPRD primary care data documentation (set 22\/january 2022). 2021. Available: https:\/\/www.cprd.com\/sites\/default\/files\/2022-02\/Documentation_HES_APC_set22.pdf [Accessed 20 Mar 2025]."},{"key":"2026102002451214000_16.10.e118484.41","unstructured":"Clinical Practice Research Datalink . Hospital episode statistics (HES) diagnostic imaging dataset and CPRD primary care data documentation (set 21). 2021. Available: https:\/\/www.cprd.com\/sites\/default\/files\/2022-02\/Documentation_HES_DID_set21_v1.7.pdf [Accessed 20 Mar 2025]."},{"key":"2026102002451214000_16.10.e118484.42","unstructured":"Clinical Practice Research Datalink . Hospital Episode Statistics (HES) Outpatient Care and CPRD primary care data Documentation (set 21), 2021. Available: https:\/\/www.cprd.com\/sites\/default\/files\/2022-02\/Documentation_HES_OP_set21.pdf [Accessed 20 Mar 2025]."},{"key":"2026102002451214000_16.10.e118484.43","unstructured":"Clinical Practice Research Datalink . Hospital episode statistics (HES) accident & emergency and CPRD primary care data documentation (set 21). 2021. Available: https:\/\/www.cprd.com\/sites\/default\/files\/2022-02\/Documentation_HES_AE_set21.pdf [Accessed 20 Mar 2025]."},{"key":"2026102002451214000_16.10.e118484.44","article-title":"Abstracts of ISPEs 2025, 41st International Conference, 22-26 August 2025, Washington DC","volume":"34 Suppl 1","year":"2025","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026102002451214000_16.10.e118484.45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-115438","article-title":"Characterising patients with Alzheimer\u2019s disease in England: a cohort study using data from Clinical Practice Research Datalink linked to Hospital Episode Statistics","volume":"16","author":"Afonso","year":"2026","journal-title":"BMJ Open"},{"key":"2026102002451214000_16.10.e118484.46","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4669"},{"key":"2026102002451214000_16.10.e118484.47","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp10X483562"},{"key":"2026102002451214000_16.10.e118484.48","doi-asserted-by":"publisher","DOI":"10.1097\/01.wad.0000165511.52746.1f"},{"key":"2026102002451214000_16.10.e118484.49","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70612","article-title":"Alzheimer\u2019s Disease Research Center Down Syndrome Cores: Experience from two sites","volume":"21","author":"Ptomey","year":"2025","journal-title":"Alzheimer's & Dementia"},{"key":"2026102002451214000_16.10.e118484.50","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70348","article-title":"Investment in Alzheimer\u2019s disease research for the next generation of adults with Down syndrome will yield health benefits for future generations","volume":"21","author":"Weden","year":"2025","journal-title":"Alzheimers Dement"},{"key":"2026102002451214000_16.10.e118484.51","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad074","article-title":"Association of biological sex with clinical outcomes and biomarkers of Alzheimer\u2019s disease in adults with Down syndrome","volume":"5","author":"Iulita","year":"2023","journal-title":"Brain Commun"},{"key":"2026102002451214000_16.10.e118484.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30689-9"},{"key":"2026102002451214000_16.10.e118484.53","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12112"},{"key":"2026102002451214000_16.10.e118484.54","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10132776","article-title":"Epilepsy in Down Syndrome: A Highly Prevalent Comorbidity","volume":"10","author":"Altuna","year":"2021","journal-title":"J Clin Med"},{"key":"2026102002451214000_16.10.e118484.55","doi-asserted-by":"publisher","DOI":"10.17294\/2330-0698.1824"},{"key":"2026102002451214000_16.10.e118484.56","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2468-2667(23)00057-9","article-title":"Multiple morbidity across the lifespan in people with Down syndrome or intellectual disabilities: a population-based cohort study using electronic health records","volume":"8","author":"Baksh","year":"2023","journal-title":"Lancet Public Health"},{"key":"2026102002451214000_16.10.e118484.57","doi-asserted-by":"crossref","unstructured":"Lauffer P , Zwaveling-Soonawala N , Li Yim AYF , et al . Multi-omics investigation of thyroid development and dysfunction in down syndrome. Hum Mol Genet 2026;35. doi:10.1093\/hmg\/ddag005","DOI":"10.1093\/hmg\/ddag005"},{"key":"2026102002451214000_16.10.e118484.58","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1586\/17446651.2015.1063995","article-title":"Thyroid function in Down syndrome","volume":"10","author":"Iughetti","year":"2015","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2026102002451214000_16.10.e118484.59","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11091220","article-title":"Cognitive Function during the Prodromal Stage of Alzheimer\u2019s Disease in Down Syndrome: Comparing Models","volume":"11","author":"Hom","year":"2021","journal-title":"Brain Sci"},{"key":"2026102002451214000_16.10.e118484.60","doi-asserted-by":"crossref","unstructured":"Paiva AF , Nolan A , Thumser C , et al . Screening of Cognitive Changes in Adults with Intellectual Disabilities: A Systematic Review. Brain Sci 2020;10. doi:10.3390\/brainsci10110848","DOI":"10.20944\/preprints202009.0739.v1"},{"key":"2026102002451214000_16.10.e118484.61","unstructured":"Down\u2019s Syndrome Association . Choosing dementia specialist care and support: a quick reference guide for families. 2025. Available: https:\/\/www.downs-syndrome.org.uk\/about-downs-syndrome\/lifes-journey\/housing-and-support-for-adults\/support\/choosing-dementia-specialist-care-support\/ [Accessed 5 Dec 2025]."},{"key":"2026102002451214000_16.10.e118484.62","first-page":"397","article-title":"Alzheimer\u2019s dementia in people with Down syndrome: Results of guideline-assisted expert interviews on healthcare deficits in the diagnostics and treatment as well as solution approaches","volume":"58","author":"Huer","year":"2025","journal-title":"Z Gerontol Geriatr"},{"key":"2026102002451214000_16.10.e118484.63","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.13505"},{"key":"2026102002451214000_16.10.e118484.64","unstructured":"Health Professional Academy . Record number of people in UK covered by private medical insurance. 2025. Available: https:\/\/www.healthprofessionalacademy.co.uk\/news\/record-number-of-people-in-uk-covered-by-private-medical-insurance [Accessed 25 Jul 2025]."},{"key":"2026102002451214000_16.10.e118484.65","unstructured":"Health Research Authority . Clinical practice research datalink (CPRD) research database. 2025. Available: https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/application-summaries\/research-summaries\/clinical-practice-research-datalink-cprd-research-database\/ [Accessed 21 Nov 2025]."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-118484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:45:31Z","timestamp":1792489531000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-118484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":65,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,20]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/bmjopen-2026-118484"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-118484","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}